US 8329924
Compounds and methods for the treatment or prevention of Flavivirus infections
granted A61KA61K31/381A61K45/06
Quick answer
US patent 8329924 (Compounds and methods for the treatment or prevention of Flavivirus infections) held by Vertex Pharmaceuticals (Canada) Incorporated expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals (Canada) Incorporated
- Grant date
- Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/381, A61K45/06, A61P, A61P31/12